Home · Health · Sep 25 archive
U.N. Agency Signs Deals for Generic Roche Flu Drug
Developing
In Short: The agency's actions reflect a proactive approach to pandemic preparedness, ensuring that generic versions of the drug can be rapidly produced and distributed if needed.
A U.N.-backed agency has signed sub-licensing deals with 11 manufacturers to develop and produce generic versions of a Roche influenza treatment, STAT reports. The move is aimed at pandemic preparedness.
The licensing agreements are part of broader efforts to ensure a steady supply of antiviral treatments in the event of a widespread flu outbreak or pandemic.
STAT notes that these deals are designed to enhance global access to the Roche drug, which is currently under patent.
The initiative underscores the importance of having multiple sources of critical medications during health crises.
The agency's actions reflect a proactive approach to pandemic preparedness, ensuring that generic versions of the drug can be rapidly produced and distributed if needed.
What's still developing
- To read the rest of this story subscribe to STAT+.
- From the lab to the medicine chest, these are the must-read drug industry updates of the day Your data will be processed in accordance with our Privacy Policy and Terms of Service.
- You may opt out of receiving STAT communications at any time.
Sources
- STATlink